The role of cell plasticity in progression and reversal of renal fibrosis

被引:26
作者
Dussaule, Jean-Claude [1 ]
Guerrot, Dominique [1 ]
Huby, Anne-Cecile [1 ]
Chadjichristos, Christos [1 ]
Shweke, Nasim [1 ]
Boffa, Jean-Jacques [1 ]
Chatziantoniou, Christos [1 ]
机构
[1] Univ Paris 06, Tenon Hosp, INSERM, UMR 702, F-75020 Paris, France
关键词
angiotensin II; endothelial-mesenchymal transition; epithelial-mesenchymal transition; podocyte; TGFbeta; vascular smooth muscle cell; HEPATOCYTE GROWTH-FACTOR; BONE MORPHOGENIC PROTEIN-7; TO-MESENCHYMAL TRANSITION; VASCULAR SMOOTH-MUSCLE; TRANSGENIC MICE; NITRIC-OXIDE; I GENE; GLOMERULAR FIBROSIS; FIBROBLASTS; REGRESSION;
D O I
10.1111/j.1365-2613.2011.00760.x
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
P>The need for novel insights into the mechanisms of progression of renal disease has become urgent during the last several years because of the increasing incidence of chronic renal disease worldwide. Independent of the underlying disease, the subsequent progression of renal fibrosis is characterized mainly by both an exaggerated synthesis and abnormal accumulation of extracellular matrix proteins produced by mesenchymal cells within the kidney. These cells are mainly myofibroblasts deriving from a variety of renal cells such as vascular smooth muscle, mesangial, resident stem, tubular epithelial, vascular endothelial cells or pericytes. The appearance of myofibroblasts is a reversible process, as suggested by studies in experimental models showing regression of renal fibrosis during therapy with antagonists and/or blockers of the renin-angiotensin system. An additional factor that can also affect the mechanisms of progression/regression of fibrosis is the plasticity of podocytes controlling glomerular filtration.
引用
收藏
页码:151 / 157
页数:7
相关论文
共 56 条
[1]   Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats [J].
Adamczak, M ;
Gross, ML ;
Krtil, J ;
Koch, A ;
Tyralla, K ;
Amann, K ;
Ritz, E .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (11) :2833-2842
[2]  
ARCINIEGAS E, 1992, J CELL SCI, V103, P521
[3]   Endothelial-mesenchymal transition occurs during embryonic pulmonary artery development [J].
Arciniegas, E ;
Neves, CY ;
Carrillo, LM ;
Zambrano, EA ;
Ramírez, R .
ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH, 2005, 12 (04) :193-200
[4]  
Ardaillou R, 1999, J AM SOC NEPHROL, V10, pS40
[5]   Microvessel vascular smooth muscle cells contribute to collagen type I deposition through ERK1/2 MAP kinase, αvβ3-integrin, and TGF-β1 in response to ANG II and high glucose [J].
Belmadani, Souad ;
Zerfaoui, Mourad ;
Boulares, Hamid A. ;
Palen, Desiree I. ;
Matrougui, Khalid .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2008, 295 (01) :H69-H76
[6]  
Berk BC, 1999, J AM SOC NEPHROL, V10, pS62
[7]   ECM remodeling in hypertensive heart disease [J].
Berk, Bradford C. ;
Fujiwara, Keigi ;
Lehoux, Stephanie .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (03) :568-575
[8]   Angiotensin II activates collagen type I gene in the renal vasculature of transgenic mice during inhibition of nitric oxide synthesis - Evidence for an endothelin-mediated mechanism [J].
Boffa, JJ ;
Tharaux, PL ;
Placier, S ;
Ardaillou, R ;
Dussaule, JC ;
Chatziantoniou, C .
CIRCULATION, 1999, 100 (18) :1901-1908
[9]   Regression of renal vascular and glomerular fibrosis: Role of angiotensin II receptor antagonism and matrix metalloproteinases [J].
Boffa, JJ ;
Lu, Y ;
Placier, S ;
Stefanski, A ;
Dussaule, JC ;
Chatziantoniou, C .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (05) :1132-1144
[10]   Regression of renal vascular fibrosis by endothelin receptor antagonism [J].
Boffa, JJ ;
Tharaux, PL ;
Dussaule, JC ;
Chatziantoniou, C .
HYPERTENSION, 2001, 37 (02) :490-496